- Home
- QFIN vs CORT Comparison
QFIN vs CORT Comparison
Compare QFIN & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QFIN
- CORT
- Stock Information
- Founded
- QFIN 2016
- CORT 1998
- Country
- QFIN China
- CORT United States
- Employees
- QFIN N/A
- CORT N/A
- Industry
- QFIN Finance: Consumer Services
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- QFIN Finance
- CORT Health Care
- Exchange
- QFIN Nasdaq
- CORT Nasdaq
- Market Cap
- QFIN 7.0B
- CORT 7.1B
- IPO Year
- QFIN 2018
- CORT N/A
- Fundamental
- Price
- QFIN $44.91
- CORT $112.29
- Analyst Decision
- QFIN Strong Buy
- CORT Strong Buy
- Analyst Count
- QFIN 2
- CORT 4
- Target Price
- QFIN $45.10
- CORT $127.00
- AVG Volume (30 Days)
- QFIN 2.3M
- CORT 1.7M
- Earning Date
- QFIN 03-16-2025
- CORT 04-30-2025
- Dividend Yield
- QFIN 2.85%
- CORT N/A
- EPS Growth
- QFIN 58.28
- CORT 30.85
- EPS
- QFIN 5.66
- CORT 1.23
- Revenue
- QFIN $2,351,749,665.00
- CORT $675,040,000.00
- Revenue This Year
- QFIN $4.84
- CORT $36.81
- Revenue Next Year
- QFIN $4.66
- CORT $29.94
- P/E Ratio
- QFIN $8.03
- CORT $92.86
- Revenue Growth
- QFIN 5.38
- CORT 39.94
- 52 Week Low
- QFIN $17.76
- CORT $20.84
- 52 Week High
- QFIN $48.94
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- QFIN 53.28
- CORT 84.76
- Support Level
- QFIN $43.30
- CORT $53.79
- Resistance Level
- QFIN $48.94
- CORT $61.09
- Average True Range (ATR)
- QFIN 2.44
- CORT 3.65
- MACD
- QFIN 0.10
- CORT 3.22
- Stochastic Oscillator
- QFIN 59.00
- CORT 97.96
About QFIN Qifu Technology Inc.
Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.